Curaleaf (Biotechnology) Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Public

  • Employees
  • 5,519

Employees

  • Stock Symbol
  • CURA

Stock Symbol

  • Investments
  • 36

  • Share Price
  • $1.16
  • (As of Friday Closing)

Curaleaf (Biotechnology) General Information

Description

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.

Contact Information

Formerly Known As
PalliaTech, PalliaTech, Inc.
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 420 Lexington Avenue
  • Suite 2035
  • New York, NY 10170
  • United States
+1 (781)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
TSE
Vertical(s)
Corporate Office
  • 420 Lexington Avenue
  • Suite 2035
  • New York, NY 10170
  • United States
+1 (781)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curaleaf (Biotechnology) Stock Performance

As of 11-Jul-2025, Curaleaf (Biotechnology)’s stock price is $1.16. Its current market cap is $913M with 757M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.16 $0.99 $0.71 - $4.45 $913M 757M 303K -$0.35

Curaleaf (Biotechnology) Financials Summary

As of 31-Mar-2025, Curaleaf (Biotechnology) has a trailing 12-month revenue of $1.31B.

In Thousands,
USD
TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 1,594,362 2,053,149 3,940,986 3,970,217
Revenue 1,313,877 1,342,802 1,346,632 1,275,420
EBITDA 221,665 232,366 187,907 167,859
Net Income (228,207) (215,423) (281,197) (370,099)
Total Assets 2,947,427 2,949,536 3,096,576 3,414,560
Total Debt 846,597 853,823 883,547 928,729
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Curaleaf (Biotechnology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Curaleaf (Biotechnology)‘s full profile, request access.

Request a free trial

Curaleaf (Biotechnology) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in t
Biotechnology
New York, NY
5,519 As of 2024

Chicago, IL
 

Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Curaleaf (Biotechnology) Competitors (8)

One of Curaleaf (Biotechnology)’s 8 competitors is Cresco Labs, a Formerly VC-backed company based in Chicago, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cresco Labs Formerly VC-backed Chicago, IL
Verano Holdings Corporation Chicago, IL
Green Thumb Industries Corporation Chicago, IL
Acreage Holdings Formerly PE-Backed New York, NY
Canopy Growth Formerly Accelerator/Incubator backed Smiths Falls, Canada
You’re viewing 5 of 8 competitors. Get the full list »

Curaleaf (Biotechnology) Patents

Curaleaf (Biotechnology) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240285705-A1 Aqueous extraction of cannabinoids Pending 28-Feb-2023
US-11629986-B2 Squeeze doser with childproof cap Active 22-Jul-2021
US-20230026087-A1 Squeeze doser with childproof cap Active 22-Jul-2021
US-20230392966-A1 Squeeze doser with childproof cap Pending 22-Jul-2021
AU-2011276505-A1 Cannabis drug delivery and monitoring system Inactive 28-Jun-2010 A61M15/0028
To view Curaleaf (Biotechnology)’s complete patent history, request access »

Curaleaf (Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curaleaf (Biotechnology) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Curaleaf (Biotechnology)‘s full profile, request access.

Request a free trial

Curaleaf (Biotechnology) Investments & Acquisitions (36)

Curaleaf (Biotechnology)’s most recent deal was a Merger/Acquisition with Brancaster Pharmaceuticals. The deal was made on 28-Jun-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Brancaster Pharmaceuticals 28-Jun-2024 Merger/Acquisition Pharmaceuticals
Northern Green Canada 22-Apr-2024 Merger/Acquisition Pharmaceuticals
Dark Heart Nursery 17-Jan-2024 Merger/Acquisition Pharmaceuticals
Half Moon Nursery 17-Jan-2024 Merger/Acquisition Cultivation
Clever Leaves (Cannabis Processing Facility in Setúbal, Portugal) 05-Jul-2023 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 36 investments and acquisitions. Get the full list »

Curaleaf (Biotechnology) ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Curaleaf (Biotechnology)’s complete esg history, request access »

Curaleaf (Biotechnology) Exits (3)

Curaleaf (Biotechnology)’s most recent exit was on 04-Oct-2021 from Los Sueños Farms. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Los Sueños Farms 04-Oct-2021 Completed
Alternative Therapies Group II 03-Nov-2020 Completed
Elevate Takoma Dispensary 10-Jan-2019 Corporate Asset Purchase Completed
To view Curaleaf (Biotechnology)’s complete exits history, request access »

Curaleaf (Biotechnology) Affiliates

Subsidiaries (5)

Name Industry Location Year Founded
Four 20 Pharma Paderborn, Germany 2018
Grassroots Cannabis Chicago, IL 2014
Northern Green Canada Brampton, Canada 2014
The Spot 420 Pueblo, CO 2013
Dark Heart Nursery San Leandro, CA 2007

Curaleaf (Biotechnology) FAQs

  • When was Curaleaf (Biotechnology) founded?

    Curaleaf (Biotechnology) was founded in 2010.

  • Where is Curaleaf (Biotechnology) headquartered?

    Curaleaf (Biotechnology) is headquartered in New York, NY.

  • What is the size of Curaleaf (Biotechnology)?

    Curaleaf (Biotechnology) has 5,519 total employees.

  • What industry is Curaleaf (Biotechnology) in?

    Curaleaf (Biotechnology)’s primary industry is Biotechnology.

  • Is Curaleaf (Biotechnology) a private or public company?

    Curaleaf (Biotechnology) is a Public company.

  • What is Curaleaf (Biotechnology)’s stock symbol?

    The ticker symbol for Curaleaf (Biotechnology) is CURA.

  • What is the current stock price of Curaleaf (Biotechnology)?

    As of 11-Jul-2025 the stock price of Curaleaf (Biotechnology) is $1.16.

  • What is the current market cap of Curaleaf (Biotechnology)?

    The current market capitalization of Curaleaf (Biotechnology) is $913M.

  • What is Curaleaf (Biotechnology)’s current revenue?

    The trailing twelve month revenue for Curaleaf (Biotechnology) is $1.31B.

  • Who are Curaleaf (Biotechnology)’s competitors?

    Cresco Labs, Verano Holdings, Green Thumb Industries, Acreage Holdings, and Canopy Growth are some of the 8 competitors of Curaleaf (Biotechnology).

  • What is Curaleaf (Biotechnology)’s annual earnings per share (EPS)?

    Curaleaf (Biotechnology)’s EPS for 12 months was -$0.35.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »